Message From The Director
The primary goal of BMEII is to develop unique approaches to biomedical sciences and therapeutic interventions by bridging basic and translational research and education by leveraging expertise in medicine and engineering. Engineering and engineering science are fundamentals to understanding the basic biomedical phenomena and associated therapeutic interventions. Major inventions and innovations that have shaped modern medicine were born out of close collaborations of engineers with biomedical researchers and clinicians, ranging from medical devices and highly sensitive and accurate bioimaging systems, to new drug target discovery and accelerated drug discovery. We have and we will continue to wisely and strategically invest in BMEII in order to lead in biomedical discovery, disease understanding and translation to patient care. By exploring our website you will learn how BMEII is unique due to its dual focus on research and education, the interrelationships between biomedical research and engineering, and spanning the molecular to human dimensions of biomedical research. I look forward to a future of advancing biomedical scientific discoveries thanks to the wonderful faculty, trainees, staff and collaborators at BMEII.
Icahn School of Medicine at Mount Sinai Unveils New PhD Concentration in Artificial Intelligence and Emerging Technologies in Medicine
Preparing future biomedical researchers with the necessary skills to tackle the field’s escalating complexity New York, NY (April 19, 2021) The Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai will offer a new PhD concentration in...
Click here to watch how BMEII researchers are learning about the debilitating long-term effects of Covid for some patients.
On February 28, NBC's Sunday Focus caught up with Zahi Fayad, PhD on BMEII's COVID-19 long-hauler studies. Click here to watch.
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Xueyan Mei, Hao-Chih Lee, […] Yang Yang
Nat Med (2020).
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Max L. Senders, Anu E. Meerwaldt, ... Willem J. M. Mulder
Nat. Nanotechnol. 15, 398–405 (2020).